AGGIES LabBLOCKMINE
ThreatDerivedConfidence: LowSnapshot Nov 8, 2026 · assessed Nov 8, 2026

Manufacturer concentration of current shortage postings: reporting-share HHI 593 over 940 entries

An HHI computed over manufacturer shares of Current shortage postings. This is a reporting-share concentration, not a market-share HHI, and says nothing about who supplies the market.

Why this matters

Illustrates the HHI method and its denominator discipline on a dataset where the denominator is actually complete; a market HHI needs trade or sales shares.

What the evidence says

  • Top manufacturers by Current postings: Fresenius Kabi USA, LLC (146), Hospira, Inc. (129), Hikma Pharmaceuticals USA Inc. (76), Baxter Healthcare Corporation (45), Eugia US LLC (42).
  • Denominator: 940 Current entries with a manufacturer name.
Current shortage postings by manufacturer (top 6).
Categorycount
Fresenius Kabi USA, LLC146
Hospira, Inc.129
Hikma Pharmaceuticals USA …76
Baxter Healthcare Corporat…45
Eugia US LLC42
Somerset Therapeutics, LLC25
Current shortage postings by manufacturer (top 6).

What remains uncertain

  • Posting counts are not market shares; a manufacturer with many package entries is over-represented.
  • No private supplier relationship is inferred.

Scoring and methodology

No score family applies to this derived count; the method is the formula stated in the evidence section.

Timeline

  1. retrieved

    Retrieved · Nov 8, 2026

  2. assessed

    Assessed · Nov 8, 2026

Event, published, retrieved, and assessed times are stored separately and never conflated.

Explore the relationships

Related insights are linked only through shared sources or mapped topics. Open the evidence graph.

What to investigate next

  • Replace with trade-flow or sales-share denominators when a licensed source is available.

Related insights

  • Supply Chain

    Derived

    The most common stated reason among 1,113 current FDA shortage entries is "Not stated" (678)

    Composition of shortage_reason among Current openFDA drug shortage records. Reasons are manufacturer-reported categories; many entries state no reason.

    Stated shortage reasons among Current entries.
    Categorycount
    Not stated678
    Other164
    Demand increase for the drug126
    Shortage of an active ingredient61
    Discontinuation of the manufacture of the drug46
    Stated shortage reasons among Current entries.
    Confidence: Moderate1 sourceSupplyFragility: not scored
    data Nov 8, 2026Read the evidence →

Export, cite, report

Found an error? Report a factual error or source correction. Last reviewed Nov 8, 2026.